Novimmune files rare disease drug in EU, after selling rights to Sobi
Deal could be worth more than $450 million
X
Novimmune files rare disease drug in EU, after selling rights to Sobi
https://pharmaphorum.com/news/novimmune-files-emapalumab/
Deal could be worth more than $450 million